View drug registration information details.

Items	Registration information
ID	267
No	267
Brand Name	AMOXIGRAN
Ingredients	AMOXYCILLIN TRIHYDRATE EQ.TO AMOXYCILLIN 250 MG/5 ML
Dosage Form	GRANULES FOR SUSPENSION
Primary Packaging	BOTTLE
Storage	STORE BELOW 30 C, PROTECT FROM MOISTURE
Shelf Life	3 YEARS
Pack Size	BOX OF 60 ML AND 100 ML/BOTTLE
Dispensing Category	Prescription only
ATC Classification	J01CA04
Pharmaceutical Class	ANTIBACTERIA
Indications	EAR, NOSE AND THROAT INFECTIONS CAUSED BY STREPTOCOCCI, PNEUMOCOCCI, NON-PENICILLINASE-PRODUCING STAPHYLOCOCCI AND H.INFLUENZA, GENITOURINARY TRACT INFECTION CAUSED BY E.COLI, P.MIRABILIS, S.FAECALIS, SKIN AND SOFT TISSUE INFECTION CAUSED BY STREPTOCOCCI, NON-PENICILLINASE-PRODUCING STAPHYLOCOCCI AND E.COLI, ANOGENITAL AND URETHRAL GONORRHOEA CAUSED BY N.GONORRHOEA
Contraindications	PATIENTS KNOWN TO BE SENSITIVE PENICILLIN, AVOID IN PATIENTS WITH INFECTIOUS MONONUCLEOSIS BECAUSE OF INCREASED RISK OF SKIN RASHES
Side Effects	RASH, HEMOLYTIC ANEMIA, ANEMIA, DIARRHEA, NAUSEA, VOMITING, BLACK HAIRY TONGUE, GLOSSITIS, STOMATITIS, SORE MOUTH OR TONGUE, ACUTE INTERSTITIAL NEPHRITIS
Unit Price	1.42
EDL	Yes
Description	WHITE TO PALE YELLOW GRANULES WITH GRENADINE FLAVOURED, WHITE TO YELLOWISH SUSPENSION UPON RECONSTITUTION
Note
License Owner	BMS PHARMA SOLE CO.,LTD
Manufacturer	HOVID BHD
Country	MALAYSIA
Import Registration No	MAL19960981AZ
Import Registration Date	31/10/2016
Activity	CERTIFICATE RELEASED
Applied Date	2022-04-08
FDD Registration No	05 I 4700/19
FDD Registration Date	2022-09-08
Expiry Date	2025-09-07

Back to drug list